Cardiovascular Devices Market Regional Analysis:
North America region is likely to hold over 40.8% market share by 2035, on the back of rising prevalence of cardiovascular diseases, increasing healthcare expenditure, and growing adoption of advanced devices. Moreover, there has been surging awareness among the people in the region related to the cardiovascular devices available on the market. As per the U.S. Centers for Medicare & Medicaid Services, the national health expenditure rose by 9.7% and reached USD 4.1 trillion in 2020, accounting for USD 12,350 per person.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cardiovascular devices is evaluated at USD 73.91 billion.
The global cardiovascular devices market size was worth over USD 69.06 billion in 2025 and is poised to grow at a CAGR of around 7.8%, reaching USD 146.36 billion revenue by 2035.
North America cardiovascular devices market will dominate over 40.8% share by 2035, driven by the rising prevalence of cardiovascular diseases and increasing healthcare expenditure.
Key players in the market include B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Terumo Corporation, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, GE Group, Siemens Healthcare GmbH.
